Dividends & Buybacks ·
Matinas BioPharma Holdings executes one-for-fifteen reverse stock split effective September 28
MTNBMatinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. filed a Certificate of Amendment to its Certificate of Incorporation with the Delaware Secretary of State on September 25, 2026, effecting a one-for-fifteen (1:15) reverse stock split of its common stock. The transaction became effective at 12:01 a.m. Eastern Time on September 28, 2026. Under the terms, every fifteen shares were converted into one share, with fractional shares cashed out rather than issued. The company anticipates trading on the NYSE American will resume on an adjusted basis on September 28, 2026, subject to exchange approval. This biotechnology company focuses on the development of pharmaceutical products.